(SSNC) SS&C Technologies Holdings - Ratings and Ratios
Portfolio, Trading, Reconciliation, Healthcare, Advisory
SSNC EPS (Earnings per Share)
SSNC Revenue
Description: SSNC SS&C Technologies Holdings
SS&C Technologies Holdings, Inc. (NASDAQ: SSNC) delivers a broad suite of software and software-enabled services to the financial services and healthcare sectors, covering the full transaction lifecycle-from front-office trading and modeling to middle-office portfolio management and back-office accounting, reconciliation, compliance, and tax reporting. The firm also provides healthcare solutions such as claims adjudication, benefit management, and care-management analytics, alongside professional consulting, implementation, and ongoing support services. Its global footprint spans North America, Europe, the Middle East, Africa, and the Asia-Pacific.
According to the FY 2023 Form 10-K, SS&C reported revenue of roughly $5.5 billion, representing a 5 % year-over-year increase driven primarily by growth in its SaaS subscription base (annual recurring revenue up 12 %). The company serves over 30,000 institutional clients, with an operating margin of about 22 %, reflecting the scalability of its cloud-native platform. Key sector drivers include accelerating regulatory compliance spending in asset management, continued migration of legacy on-premise systems to cloud solutions, and heightened demand for data-analytics tools to meet ESG reporting requirements.
If you want a data-rich, side-by-side comparison of SSNC’s valuation multiples, growth trends, and competitive positioning, the ValueRay platform provides a transparent dashboard that can help deepen your analysis.
SSNC Stock Overview
Market Cap in USD | 20,097m |
Sub-Industry | Application Software |
IPO / Inception | 1996-05-31 |
SSNC Stock Ratings
Growth Rating | 68.6% |
Fundamental | 66.4% |
Dividend Rating | 68.4% |
Return 12m vs S&P 500 | -8.53% |
Analyst Rating | 4.33 of 5 |
SSNC Dividends
Dividend Yield 12m | 1.28% |
Yield on Cost 5y | 1.69% |
Annual Growth 5y | 16.61% |
Payout Consistency | 100.0% |
Payout Ratio | 23.0% |
SSNC Growth Ratios
Growth Correlation 3m | 22.5% |
Growth Correlation 12m | 72.9% |
Growth Correlation 5y | 29.6% |
CAGR 5y | 20.82% |
CAGR/Max DD 3y (Calmar Ratio) | 0.92 |
CAGR/Mean DD 3y (Pain Ratio) | 3.55 |
Sharpe Ratio 12m | 1.00 |
Alpha | -10.33 |
Beta | 1.234 |
Volatility | 33.97% |
Current Volume | 1298.2k |
Average Volume 20d | 1202.1k |
Stop Loss | 77.1 (-3.1%) |
Signal | -0.76 |
Piotroski VR‑10 (Strict, 0-10) 5.0
Net Income (806.4m TTM) > 0 and > 6% of Revenue (6% = 362.8m TTM) |
FCFTA 0.08 (>2.0%) and ΔFCFTA 2.09pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
NWC/Revenue 9.24% (prev 7.78%; Δ 1.47pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
CFO/TA 0.08 (>3.0%) and CFO 1.44b > Net Income 806.4m (YES >=105%, WARN >=100%) |
Net Debt (4.13b) to EBITDA (2.10b) ratio: 1.96 <= 3.0 (WARN <= 3.5) |
Current Ratio 1.14 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
Outstanding Shares last Quarter (252.2m) change vs 12m ago -0.04% (target <= -2.0% for YES) |
Gross Margin 48.66% (prev 49.07%; Δ -0.41pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
Asset Turnover 33.69% (prev 33.50%; Δ 0.19pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
Interest Coverage Ratio 3.17 (EBITDA TTM 2.10b / Interest Expense TTM 444.4m) >= 6 (WARN >= 3) |
Altman Z'' 1.71
(A) 0.03 = (Total Current Assets 4.66b - Total Current Liabilities 4.10b) / Total Assets 18.98b |
(B) 0.21 = Retained Earnings (Balance) 3.91b / Total Assets 18.98b |
(C) 0.08 = EBIT TTM 1.41b / Avg Total Assets 17.94b |
(D) 0.31 = Book Value of Equity 3.67b / Total Liabilities 11.97b |
Total Rating: 1.71 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 66.42
1. Piotroski 5.0pt = 0.0 |
2. FCF Yield 6.04% = 3.02 |
3. FCF Margin 24.20% = 6.05 |
4. Debt/Equity 1.01 = 2.01 |
5. Debt/Ebitda 1.96 = 0.07 |
6. ROIC - WACC (= -0.36)% = -0.45 |
7. RoE 11.92% = 0.99 |
8. Rev. Trend 98.30% = 7.37 |
9. EPS Trend -52.97% = -2.65 |
What is the price of SSNC shares?
Over the past week, the price has changed by -6.08%, over one month by -10.08%, over three months by -3.54% and over the past year by +5.03%.
Is SS&C Technologies Holdings a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SSNC is around 76.69 USD . This means that SSNC is currently overvalued and has a potential downside of -3.58%.
Is SSNC a buy, sell or hold?
- Strong Buy: 6
- Buy: 4
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the SSNC price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | 97.9 | 23.1% |
Analysts Target Price | 97.9 | 23.1% |
ValueRay Target Price | 85.2 | 7.1% |
Last update: 2025-10-13 02:04
SSNC Fundamental Data Overview
P/E Trailing = 25.959
P/E Forward = 13.4771
P/S = 3.3239
P/B = 3.0808
P/EG = 0.9232
Beta = 1.234
Revenue TTM = 6.05b USD
EBIT TTM = 1.41b USD
EBITDA TTM = 2.10b USD
Long Term Debt = 6.80b USD (from longTermDebt, last quarter)
Short Term Debt = 20.0m USD (from shortTermDebt, last quarter)
Debt = 7.02b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.13b USD (from netDebt column, last quarter)
Enterprise Value = 24.22b USD (20.10b + Debt 7.02b - CCE 2.89b)
Interest Coverage Ratio = 3.17 (Ebit TTM 1.41b / Interest Expense TTM 444.4m)
FCF Yield = 6.04% (FCF TTM 1.46b / Enterprise Value 24.22b)
FCF Margin = 24.20% (FCF TTM 1.46b / Revenue TTM 6.05b)
Net Margin = 13.34% (Net Income TTM 806.4m / Revenue TTM 6.05b)
Gross Margin = 48.66% ((Revenue TTM 6.05b - Cost of Revenue TTM 3.10b) / Revenue TTM)
Gross Margin QoQ = 47.95% (prev 49.35%)
Tobins Q-Ratio = 1.28 (Enterprise Value 24.22b / Total Assets 18.98b)
Interest Expense / Debt = 1.50% (Interest Expense 105.5m / Debt 7.02b)
Taxrate = 24.38% (58.4m / 239.5m)
NOPAT = 1.07b (EBIT 1.41b * (1 - 24.38%))
Current Ratio = 1.14 (Total Current Assets 4.66b / Total Current Liabilities 4.10b)
Debt / Equity = 1.01 (Debt 7.02b / totalStockholderEquity, last quarter 6.93b)
Debt / EBITDA = 1.96 (Net Debt 4.13b / EBITDA 2.10b)
Debt / FCF = 2.82 (Net Debt 4.13b / FCF TTM 1.46b)
Total Stockholder Equity = 6.77b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.25% (Net Income 806.4m / Total Assets 18.98b)
RoE = 11.92% (Net Income TTM 806.4m / Total Stockholder Equity 6.77b)
RoCE = 10.39% (EBIT 1.41b / Capital Employed (Equity 6.77b + L.T.Debt 6.80b))
RoIC = 7.76% (NOPAT 1.07b / Invested Capital 13.74b)
WACC = 8.12% (E(20.10b)/V(27.11b) * Re(10.56%) + D(7.02b)/V(27.11b) * Rd(1.50%) * (1-Tc(0.24)))
Discount Rate = 10.56% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.02%
[DCF Debug] Terminal Value 68.47% ; FCFE base≈1.26b ; Y1≈1.18b ; Y5≈1.11b
Fair Price DCF = 54.95 (DCF Value 13.42b / Shares Outstanding 244.2m; 5y FCF grow -7.51% → 3.0% )
EPS Correlation: -52.97 | EPS CAGR: -58.13% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.30 | Revenue CAGR: 5.66% | SUE: 1.41 | # QB: 1
Additional Sources for SSNC Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle